Konstantinos Alataris PhD is a serial entrepreneur with a track record in building healthcare companies focused on innovation and driving adoption of new therapeutics. Konstantinos has decades of experience in the biotechnology and medical device industries as a company founder, chief executive officer, investor and board member.

Konstantinos was the founder and CEO of Nevro (NYSE: NVRO) where under his leadership, Nevro advanced Senza®, its implantable therapeutic, from concept to commercialization for neurological disorders. Also was the founder and CEO of Nēsos, that designed and tested in the clinic, disease modifying neuro-immunotherapeutics to restore autonomic control of the immune response. Nēsos' clinical portfolio focused on autoimmune, neurological and neuropsychiatric disorders.

Dr. Alataris received Master’s degrees in Electrical Engineering and Business and a Ph.D. in Biomedical Engineering with focus in Computational Neuroscience from the University of Southern California. He received a Bachelor of Science in Electrical and Computer Engineering from the National Technical University of Athens, Greece.